Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥3,670 JPY
Change Today -40.00 / -1.08%
Volume 985.2K
As of 1:30 AM 05/7/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-Jacques Garaud M.D.

AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 4 different industries.

See Board Relationships
59--

Background*

Dr. Jean-Jacques Garaud, M.D served as an Advisor of Inserm Transfert Initiative. Dr. Garaud served as Head of Pharmaceutical Research at Roche Holding AG until July 5, 2014. He served as the Head of Roche Pharma Research and Early Development of Roche Holding AG (also known as F. Hoffmann-La Roche) since January 1, 2010 until 2012. He served as the Head of Global Pharma Development for Roche Holding AG. Prior to joining F. Hoffmann-La Roche Ltd. in 2007, Dr. Garaud ...

Read Full Background

Corporate Headquarters*

1-1 Nihonbashi-Muromachi 2-Chome
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships*

Former Director
2012-Present
Independent Non-Executive Director, Chairman of Remuneration Committee, Member of Audit Committee and Member of Nomination Committee
2013-Present
Director

Education*

MD 1981
Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4519:JP ¥3,670.00 JPY -40.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
SFr.6.1M
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.